製品: Albumin Antibody
カタログ: DF6396
タンパク質の説明: Rabbit polyclonal antibody to Albumin
アプリケーション: WB IHC
反応性: Human, Mouse, Rat
分子量: 69kDa; 69kD(Calculated).
ユニプロット: P02768
RRID: AB_2838359

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
クローナリティ:
Polyclonal
特異性:
Albumin Antibody detects endogenous levels of total Albumin.
RRID:
AB_2838359
引用形式: Affinity Biosciences Cat# DF6396, RRID:AB_2838359.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

alb; ALBU_HUMAN; Albumin (32 AA); Albumin (AA 34); Albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; PRO0883; PRO0903; PRO1341; Serum albumin;

免疫原

免疫原:
Uniprot:
遺伝子(ID):
発現特異性:
タンパク質の説明:
Serum albumin is the most abundant protein in plasma. It accounts for over 50% of total human plasma protein content, having a concentration of approximately 40 g/L. Albumin is predominantly synthesized in the liver and is a major transportation component for many endogenous and exogenous compounds, including fatty acids, steroid hormones, metabolites and drugs. It is also responsible for maintaining colloid osmotic pressure and may affect microvascular integrity (1).
タンパク質配列:
MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL

PTMs - P02768 基板として

Site PTM Type Enzyme
S14 Phosphorylation
Y17 Phosphorylation
S18 Phosphorylation
S29 Phosphorylation
K44 Acetylation
Y54 Phosphorylation
C58 S-Nitrosylation
K65 Acetylation
T71 Phosphorylation
K75 Acetylation
K75 Methylation
C77 S-Nitrosylation
S82 Phosphorylation
C86 S-Nitrosylation
S89 Phosphorylation
T92 Phosphorylation
C99 S-Nitrosylation
T107 Phosphorylation
Y108 Phosphorylation
C114 S-Nitrosylation
C115 S-Nitrosylation
K117 Acetylation
C125 S-Nitrosylation
K130 Acetylation
C148 S-Nitrosylation
K160 Acetylation
K161 Acetylation
Y162 Phosphorylation
Y164 Phosphorylation
R168 Methylation
Y172 Phosphorylation
Y174 Phosphorylation
K183 Acetylation
K186 Acetylation
T190 Phosphorylation
C192 S-Nitrosylation
C193 S-Nitrosylation
K198 Acetylation
C201 S-Nitrosylation
K214 Acetylation
S216 Phosphorylation
S217 Phosphorylation
K219 Acetylation
K223 Acetylation
K229 Acetylation
K229 Ubiquitination
S244 Phosphorylation
K249 Acetylation
S256 Phosphorylation
K257 Acetylation
T260 Phosphorylation
T263 Phosphorylation
K264 Acetylation
C269 S-Nitrosylation
C270 S-Nitrosylation
K286 Acetylation
Y287 Phosphorylation
C289 S-Nitrosylation
S294 Phosphorylation
S296 Phosphorylation
S297 Phosphorylation
K298 Acetylation
K298 Ubiquitination
K300 Acetylation
C303 S-Nitrosylation
K305 Acetylation
S311 Phosphorylation
C313 S-Nitrosylation
S328 Phosphorylation
S336 Phosphorylation
Y343 Phosphorylation
K347 Acetylation
Y365 Phosphorylation
S366 Phosphorylation
T376 Phosphorylation
Y377 Phosphorylation
T379 Phosphorylation
T380 Phosphorylation
C385 S-Nitrosylation
Y394 Phosphorylation
K396 Acetylation
K402 Acetylation
C416 S-Nitrosylation
Y425 Phosphorylation
K426 Acetylation
T436 Phosphorylation
K438 Acetylation
S443 Phosphorylation
T444 O-Glycosylation
T444 Phosphorylation
T446 Phosphorylation
S451 Phosphorylation
K456 Acetylation
K468 Acetylation
C472 S-Nitrosylation
Y476 Phosphorylation
C485 S-Nitrosylation
K490 Methylation
T498 Phosphorylation
K499 Acetylation
C500 S-Nitrosylation
T502 Phosphorylation
S504 Phosphorylation
C511 S-Nitrosylation
S513 Phosphorylation
T520 Phosphorylation
Y521 Phosphorylation
K524 Acetylation
C538 S-Nitrosylation
K549 Acetylation
T551 Phosphorylation
K558 Acetylation
K558 Methylation
K562 Acetylation
T564 Phosphorylation
T590 Phosphorylation
C591 S-Nitrosylation
K597 Acetylation
K598 Acetylation
S603 Phosphorylation

研究背景

機能:

Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs (Probable). Its main function is the regulation of the colloidal osmotic pressure of blood (Probable). Major zinc transporter in plasma, typically binds about 80% of all plasma zinc. Major calcium and magnesium transporter in plasma, binds approximately 45% of circulating calcium and magnesium in plasma (By similarity). Potentially has more than two calcium-binding sites and might additionally bind calcium in a non-specific manner (By similarity). The shared binding site between zinc and calcium at residue Asp-273 suggests a crosstalk between zinc and calcium transport in the blood (By similarity). The rank order of affinity is zinc > calcium > magnesium (By similarity). Binds to the bacterial siderophore enterobactin and inhibits enterobactin-mediated iron uptake of E.coli from ferric transferrin, and may thereby limit the utilization of iron and growth of enteric bacteria such as E.coli. Does not prevent iron uptake by the bacterial siderophore aerobactin.

PTMs:

Kenitra variant is partially O-glycosylated at Thr-620. It has two new disulfide bonds Cys-600 to Cys-602 and Cys-601 to Cys-606.

Glycated in diabetic patients.

Phosphorylated by FAM20C in the extracellular medium.

Acetylated on Lys-223 by acetylsalicylic acid.

細胞の位置付け:

Secreted.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Plasma.

サブユニット構造:

Interacts with FCGRT; this interaction regulates ALB homeostasis.

タンパク質ファミリー:

Belongs to the ALB/AFP/VDB family.

研究領域

· Organismal Systems > Endocrine system > Thyroid hormone synthesis.

参考文献

1). Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity. Biomedicine & Pharmacotherapy, 2021 (PubMed: 34311530) [IF=7.5]

2). Factor XII and prekallikrein promote microvascular inflammation and psoriasis in mice. British journal of pharmacology, 2024 (PubMed: 38872396) [IF=7.3]

3). Discovery and validation of extracellular vesicle‐associated miRNAs as noninvasive detection biomarkers for early‐stage non‐small‐cell lung cancer. Molecular Oncology, 2021 (PubMed: 33340250) [IF=6.6]

Application: WB    Species: Human    Sample: lung tissues

Figure 1. Characterisation of EVs derived from the serum and plasma of NSCLC patients and controls. (a) The shape and structure of serum and plasma EVs isolated by EXOquick kit under TEM. The red arrow represents EVs with typical characteristics (scale bars are 200 nm). (b) The size of EVs derived from control groups and NSCLC groups was analysed by NTA. (c) Western blots of EVs membrane markers, including Alix, CD63, TSG101, CD9, and one negative marker ALB.

4). Network pharmacology-based analysis of Jin-Si-Wei on the treatment of Alzheimer's disease. Journal of ethnopharmacology, 2023 (PubMed: 37925002) [IF=5.4]

5). An Engineered Protein-Based Building Block (Albumin Methacryloyl) for Fabrication of a 3D In Vitro Cryogel Model. Gels, 2022 (PubMed: 35877489) [IF=4.6]

6). Transient Inhibition of mTORC1 Signaling Ameliorates Irradiation-Induced Liver Damage. Frontiers in Physiology, 2019 (PubMed: 30984007) [IF=4.0]

Application: WB    Species: mouse    Sample: Liver

FIGURE 1 | Irradiation-induced liver damage in mice. C57BL/6J mice were exposed to 8.0 Gy of total body irradiation (TBI). Liver tissues were harvested at days 1, 3, and 7 post-exposure (n = 6). (A) Representative pictures by HE staining are shown. Scale bar = 50 μm. Arrows indicate edema hepatocytes. (B and C) ALB and AFP expression in liver tissues (n = 3). Expression of ALB (B) and AFP (C) was detected by western blotting.

7). Network pharmacology‑based study to explore the mechanism of the Yiqi Gubiao pill in lung cancer treatment. Oncology Letters, 2021 (PubMed: 33692853) [IF=2.9]

8). Advanced oxidation protein products induce annulus fibrosus cell senescence through a NOX4-dependent, MAPK-mediated pathway and accelerate intervertebral disc degeneration. PeerJ, 2022 (PubMed: 35935259) [IF=2.7]

Application: WB    Species: Rat    Sample: AF cells

Figure 1 AOPPs accumulate in IVDD, up-regulate the expression of NOX4, senescence markers, and their associated inflammatory proteins, and accelerate IVDD. (A) MRI of a persistent lumbar degeneration model showed significant disc degeneration. (B) Immunofluorescence of AOPPs showed massive accumulation of AOPPs in AF tissues at two months of degenerative discs. Scale bar: 25 µm. (C) The DMMB assay of the rat lumbar discs showed a gradual decrease in GAG content after surgery, suggesting IVDD. (D) Western blot analysis of lumbar discs showed that albumin and AOPPs accumulated in IVDD, up-regulating NOX4, senescence markers p53, p21, p16, and senescence-associated inflammatory proteins IL-1β and TNF-α expression. (E) Western blot analysis of the caudal discs showed that albumin and AOPPs accumulated in IVDD up-regulated the expression of NOX4, senescence markers, and senescence-associated inflammatory proteins. (F) X-rays of Co6/7 and Co8/9 showed lower DHI in the puncture + intra-discal AOPPs group. (G, H, I) Immunohistochemical staining of AF tissue for p16 and NOX4 was positive in the punctured discs and much higher after stimulation with exogenous AOPPs. Scale bars: 100 µm and 200 µm. (J) DMMB measurements of rat lumbar discs showed a decrease in GAG content in all puncture groups, indicating IVDD in all puncture groups, with the lowest content and most severe degeneration in the intra-discal injection AOPPs group. Sham, sham surgery. IP, intra-peritoneal injection. N = 6 per group. *P < 0.05 compared to Sham and IP for AOPPs. ** P < 0.01 compared to Sham and IP for AOPPs. #P < 0.05 compared to the other five groups. All experiments were repeated at least three times. Error bars represent standard errors.

9). BMAL1 attenuates intracerebral hemorrhage-induced secondary brain injury in rats by regulating the Nrf2 signaling pathway. Annals of Translational Medicine, 2021 (PubMed: 34926661)

Application: WB    Species: Rat    Sample:

Figure 2 Effects of BMAL1 overexpression on oxidative stress, BBB injury, brain edema, inflammation and neurobehaviors after ICH. (A) Western blot analysis of levels of the BMAL1 and Albumin proteins (index of BBB injury) in the sham, ICH, ICH + Vector and ICH + Over-BMAL1 groups at 24 h after ICH. (B) Quantification of the relative BMAL1 protein levels in the four groups. (C) ROS levels in the brain tissues from rats in the four groups. (D) Quantification of the relative Albumin protein levels in the four groups. (E) The effects of BMAL1 overexpression on the brain water content of rats in the four groups. (F) Concentrations of IL-1β in the serum of the sham ICH, ICH + Vector and ICH+Over-BMAL1 groups at 24 h after ICH. (G) Concentrations of TNF-α in the serum of the four groups listed above. (H) The scores on the modified Garcia test in the sham, ICH, ICH + Vector and ICH + Over-BMAL1 groups at 24 h after ICH. (I) Representative images illustrate swimming trajectories at 25 d (learning) and escape latency in the Morris water maze test at 21 to 25 d after ICH in the sham, ICH, ICH + Vector and ICH + Over BMAL1 rats. (J) Representative images illustrate swimming trajectories at 26 d (memory) and time spent in the platform quadrant in the Morris water maze test at 26 d after ICH in the groups listed above. **P

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.